Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment
Open Access
- 1 December 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 68 (12) , 1309-1318
Abstract
Nerve growth factor (NGF)-dependent cholinergic basal forebrain neurons degenerate during the progression of Alzheimer disease (AD). Elevated proNGF aKeywords
This publication has 77 references indexed in Scilit:
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer diseaseNeurobiology of Aging, 2009
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics, 2008
- Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascadeProceedings of the National Academy of Sciences, 2006
- A TrkA-to-p75NTR molecular switch activates amyloid β-peptide generation during agingBiochemical Journal, 2005
- Sortilin is essential for proNGF-induced neuronal cell deathNature, 2004
- Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's diseaseNeurochemistry International, 2003
- Reliability of the National Institutes of Health Stroke ScaleStroke, 1997
- Proteolysis of Aβ Peptide from Alzheimer Disease Brain by Gelatinase ABiochemical and Biophysical Research Communications, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984